John W. Babich

John W. Babich appears in our data through filings on Molecular Insight Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 1 February 2007 to 20 May 2008.

On the market, this insider has only ever bought: 4 purchases, €60k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise.

Half of the purchases are above €14k and half below.

On 22 May 2008 came the latest disclosure, a share grant for €190 in Molecular Insight Pharmaceuticals, Inc. The last purchase on record was published on 4 December 2007, which is 6,915 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.